An update on borderline personality disorder: life in the fast lane

Several studies have been conducted for a long time to identify the borderline personality and to elucidate its distinctivecharacteristics from other psychopathologies. However, the different findings obtained in these studies carried outprovided findings that this disorder is not yet understood sufficiently. Therefore, studies about the prevalence, thecomorbidity, causative factors and treatment approaches of borderline personality disorder are of vital importance.Moreover, studies about suicidality among BPD patients also have a separate importance because repetitive suicidalbehaviors complicate the medical care significantly. In this review, we aimed to reevaluate the recent studies conductedon the diagnosis, the prevalence, the comorbidity, causative factors, and treatment of borderline personality disorder.

PDF

___

1. Kernberg O. Borderline personality organization. J Am Psychoanal Assoc. 1967;15(3):641-85. [CrossRef]
2. American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 3th edition, Washington, DC: APA, 1980.
3. McGlashan TH. The Chestnut Lodge follow-up study. III. Longterm outcome of borderline personalities. Arch Gen Psychiatry. 1986;43(1):20-30. [CrossRef]
4. Paris J, Brown R, Nowlis D. Long-term follow-up of borderline patients in a general hospital. Compr Psychiatry. 1987;28(6):530-5. [CrossRef]
5. Plakun EM, Burkhardt PE, Muller JP. 14-year follow-up of borderline and schizotypal personality disorders. Compr Psychiatry. 1985;26(5):448-55. [CrossRef]
6. Stone MH. The fate of borderline patients. New York, NY: Guilford Press, 1990.
7. Paris J, Zweig-Frank H. A 27-year follow-up of patients with borderline personality disorder. Compr Psychiatry. 2001;42(6):482- 7. [CrossRef]
8. Gunderson JG, Stout RL, McGlashan TH, Shea MT, Morey LC, Grilo CM, Zanarini MC, Yen S, Markowitz JC, Sanislow C, Ansell E, Pinto A, Skodol AE. Ten-year course of borderline personality disorder: psychopathology and function from the Collaborative Longitudinal Personality Disorders study. Arch Gen Psychiatry. 2011;68(8):827-37. [CrossRef]
9. Zanarini MC, Frankenburg FR, Reich DB, Fitzmaurice G. Time to attainment of recovery from borderline personality disorder and stability of recovery: A 10-year prospective follow-up study. Am J Psychiatry. 2010;167(6):663-7. [CrossRef]
10. Alvarez-Tomás I, Soler J, Bados A, Martín-Blanco A, Elices M, Carmona C, Bauzà J, Pascual JC. Long-Term Course of Borderline Personality Disorder: A Prospective 10-Year Follow-Up Study. J Pers Disord. 2016;17:1-16. [CrossRef]
11. Gunderson JG, Kolb JE. Discriminating features of borderline patients. Am J Psychiatry. 1978;135(7):792-6. [CrossRef]
12. American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 5th edition, Washington, DC: APA, 2013.
13. Samuels J, Eaton WW, Bienvenu OJ 3rd, Brown CH, Costa PT Jr, Nestadt G. Prevalence and correlates of personality disorders in a community sample. Br J Psychiatry. 2002;180:536-42. [CrossRef]
14. Torgersen S, Kringlen E, Cramer V. The prevalence of personality disorders in a community sample. Arch Gen Psychiatry. 2001;58(6):590-6. [CrossRef]
15. Gunderson JG. Clinical practice: borderline personality disorder. N Engl J Med. 2011;364(21):2037-42. [CrossRef]
16. Meaney R, Hasking P, Reupert A. Prevalence of Borderline Personality Disorder in University Samples: Systematic Review, Meta-Analysis and Meta-Regression. PLoS One. 2016;11(5):e0155439. [CrossRef]
17. Distel MA, Trull TJ, Willemsen G, Vink JM, Derom CA, Lynskey M, Martin NG, Boomsma DI. The five-factor model of personality and borderline personality disorder: a genetic analysis of comorbidity. Biol Psychiatry. 2009;66(12):1131-8. [CrossRef]
18. McCormick B, Blum N, Hansel R, Franklin JA, St John D, Pfohl B, Allen J, Black DW. Relationship of sex to symptom severity, psychiatric comorbidity, and health care utilization in 163 subjects with borderline personality disorder. Compr Psychiatry. 2007;48(5):406-12. [CrossRef]
19. Paris J. The nature of borderline personality disorder: multiple dimensions, multiple symptoms, but one category. J Pers Disord. 2007;21(5):457-73. [CrossRef]
20. Barrachina J, Pascual JC, Ferrer M, Soler J, Rufat MJ, Andión O, Tiana T, Martín-Blanco A, Casas M, Pérez V. Axis II comorbidity in borderline personality disorder is influenced by sex, age, and clinical severity. Compr Psychiatry. 2011;52(6):725-30. [CrossRef]
21. Zanarini MC, Gunderson JG, Frankenburg FR. Axis I phenomenology of borderline personality disorder. Compr Psychiatry. 1989;30(2):149-56. [CrossRef]
22. Zlotnick C, Rothschild L, Zimmerman M. The role of gender in the clinical presentation of patients with borderline personality disorder. J Personal Disord. 2002;16(3):277-82. [CrossRef]
23. Grilo CM, Anez LM, McGlashan TH. DSM-IV axis II comorbidity with borderline personality disorder in monolingual Hispanic psychiatric outpatients. J Nerv Ment Dis. 2002;190(5):324-30. [CrossRef]
24. Grant BF, Chou SP, Goldstein RB, Huang B, Stinson FS, Saha TD, Smith SM, Dawson DA, Pulay AJ, Pickering RP, Ruan WJ. Prevalence, correlates, disability, and comorbidity of DSM-IV borderline personality disorder: results from the Wave 2 National Epidemiologic Survey on Alcohol and Related Conditions. J Clin Psychiatry. 2008;69(4):533-45. [CrossRef]
25. Shen CC, Hu LY, Hu YH. Comorbidity study of borderline personality disorder: applying association rule mining to the Taiwan national health insurance research database. BMC Med Inform Decis Mak. 2017;17(1):8. [CrossRef]
26. Zanarini MC, Frankenburg FR, Dubo ED, Sickel AE, Trikha A, Levin A, Reynolds V. Axis I comorbidity of borderline personality disorder. Am J Psychiatry. 1998;155(12):1733-9. [CrossRef]
27. Zanarini MC, Frankenburg FR, Dubo ED, Sickel AE, Trikha A, Levin A, Reynolds V. Axis II comorbidity of borderline personality disorder. Compr Psychiatry. 1998;39(5):296-302. [CrossRef]
28. Leichsenring F, Leibing E, Kruse J, New AS, Leweke F. Borderline personality disorder. Lancet. 2011;377(9759):74-84. [CrossRef]
29. Torgersen S, Myers J, Reichborn-Kjennerud T, Røysamb E, Kubarych TS, Kendler KS. The heritability of Cluster B personality disorders assessed both by personal interview and questionnaire. J Pers Disord. 2012;26(6):848-66. [CrossRef]
30. Judd PH, McGlashan TH. A Developmental Model of Borderline Personality Disorder: Understanding Variations in Course and Outcome. Washington, DC: American Psychiatric Publishing, 2003.
31. Videbeck SL. Psychiatric Mental Health Nursing. Philadelphia: Lippincott Williams & Wilkin, 2001.
32. Fossati A, Madeddu F, Maffei C. Borderline Personality Disorder and childhood sexual abuse: a meta-analytic study. J Pers Disord. 1999;13(3):268-80. [CrossRef]
33. Paris J. Childhood trauma as an etiological factor in the personality disorders. J Pers Disord. 1997;11(1):34-49. [CrossRef]
34. Laporte L, Guttman H. Traumatic childhood experiences as risk factors for borderline and other personality disorders. J Personal Disord. 1996;10(3):247-59. [CrossRef]
35. Golier JA, Yehuda R, Bierer LM, Mitropoulou V, New AS, Schmeidler J, Silverman JM, Siever LJ. The relationship of borderline personality disorder to posttraumatic stress disorder and traumatic events. Am J Psychiatry. 2003;160(11):2018-24. [CrossRef]
36. Helgeland MI, Torgersen S. Developmental antecedents of borderline personality disorder. Compr Psychiatry. 2004;45(2):138- 47. [CrossRef]
37. Paris J. Borderline personality disorder. CMAJ. 2005;172(12):1579- 83. [CrossRef]
38. Links PS, Heslegrave R, van Reekum R. Impulsivity: core aspect of borderline personality disorder. J Pers Disord. 1999;13(1):1-9. [CrossRef]
39. Wedig MM, Silverman MH, Frankenburg FR, Reich DB, Fitzmaurice G, Zanarini MC. Predictors of suicide attempts in patients with borderline personality disorder over 16 years of prospective follow-up. Psychol Med. 2012;42:2395-404. [CrossRef]
40. Brodsky BS, Malone KM, Ellis SP, Dulit RA, Mann JJ. Characteristics of borderline personality disorder associated with suicidal behavior. Psychiatry. 1997;154(2):1715-9. [CrossRef]
41. Soloff PH, Fabio A. Prospective predictors of suicide attempts in borderline personality disorder at one, two, and two-to-five year follow-up. J Personal Disord. 2008;22(2):123-34. [CrossRef]
42. Soloff PH, Pruitt P, Sharma M, Radwan J, White R, Diwadkar VA. Structural brain abnormalities and suicidal behavior in borderline personality disorder. J Psychiatr Res. 2012;46(4):516-25. [CrossRef]
43. Wolf RC, Thomann PA, Sambataro F et al. Orbitofrontal cortex and impulsivity in borderline personality disorder: an MRI study of baseline brain perfusion. Eur Arch Psychiatry Clin Neurosci. 2012;262:677-85. [CrossRef]
44. Teicher MH, Andersen SL, Polcari A, et al. The neurobiological consequences of early stress and childhood maltreatment. Neurosci Biobehav Rev. 2003;27:33-44. [CrossRef]
45. Zanarini MC. Frankenburg FR. Parachini EA. A preliminary, randomized trial of fluoxetine, olanzapine, and the olanzapine– fluoxetine combination in women with borderline personality disorder. J Clin Psychiatry. 2004;65:903-7. [CrossRef]
46. Linehan MM, Armstrong HE, Suarez A, Allmon D, Heard H. Cognitive behavioral treatment of chronically parasuicidal borderline patients. Arch Gen Psychiatry. 1991;48:1060-4. [CrossRef]
47. Simpson EB, Yen S, Costello E, Rosen K, Begin A, Pistorello J, et al. Combined dialectical behavior therapy and fluoxetine in the treatment of borderline personality disorder. J Clin Psychiatry. 2004;65:379-85. [CrossRef]
48. Bateman A, Fonagy P. Effectiveness of partial hospitalization in the treatment of borderline personality disorder: a randomized controlled trial. Am J Psychiatry. 1999;156:1563-9. [CrossRef]
49. Zanarini MC, Frankenburg FR. Olanzapine treatment of female borderline personality disorder patients: a double-blind, placebocontrolled pilot study. J Clin Psychiatry. 2001;62:849-54. [CrossRef]
50. Rinne T, van den Brink W, Wouters L, van Dyck R. SSRI treatment of borderline personality disorder: a randomized, placebo-controlled clinical trial for female patients with borderline personality disorder. Am J Psychiatry. 2002;159:2048-54. [CrossRef]
51. Salzman C, Wolfson AN, Schatzberg A, Looper J, Henke R, Albanese M, et al. Effect of fluoxetine on anger in symptomatic volunteers with borderline personality disorder. J Clin Psychopharmacol. 1995;15:23-9. [CrossRef]
52. Coccaro EF, Kavoussi RJ. Fluoxetine and impulsive aggressive behavior in personality-disordered subjects. Arch Gen Psychiatry. 1997;54:1081-8. [CrossRef]
53. Hollander E, Swann AC, Coccaro EF, Jiang P, Smith TB. Impact of trait impulsivity and state aggression on divalproex versus placebo response in borderline personality disorder. Am J Psychiatry. 2005;162:621-4. [CrossRef]
54. Frankenburg FR, Zanarini MC. Divalproex sodium treatment of women with borderline personality disorder and bipolar II disorder: a double-blind placebo-controlled pilot study. J Clin Psychiatry. 2002;63:442-6. [CrossRef]
55. Shea MT, Pilkonis PA, Beckham E, Collins JF, Elikin E, Sotsky SM, et al. Personality disorders and treatment outcome in the NIMH Treatment of Depression Collaborative Research Program. Am J Psychiatry. 1990;147:711-8. [CrossRef]
56. Soloff P. Psychopharmacological treatment of borderline personality disorder. Psychiatr Clin North Am. 2000;23:169-92. [CrossRef]
57. Linehan M. Cognitive-behavioral treatment of borderline personality disorder. New York (NY): Guilford Press; 1993. p. 558.